Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 3/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18252554 | 1.00 | ALOX5 (0.61) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252607 | 1.00 | ALOX5 (0.61) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252603 | 1.00 | ALOX5 (0.61) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252608 | 0.97 | ALOX5 (0.64) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252473 | 0.94 | ALOX5 (0.55) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL20277131 | 0.92 | ALOX5 (0.69) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252202 | 0.92 | ALOX5 (0.69) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252556 | 0.92 | ALOX5 (0.69) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL12069400 | 0.92 | ALOX5 (0.69) | ALOX5GGPS1PRKDCNPC1MAPT | |
| SCHEMBL18252568 | 0.91 | ALOX5 (0.61) | ALOX5GGPS1PRKDCNPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256411-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885GGPS1 47/4885PRKDC 2829/4885 |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885GGPS1 47/4885PRKDC 2829/4885 |
| US-10256411-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885GGPS1 47/4885PRKDC 2829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.